Form 8-K - Current report:
SEC Accession No. 0001485003-23-000014
Filing Date
2023-01-31
Accepted
2023-01-31 16:02:21
Documents
16
Period of Report
2023-01-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesn-20230131.htm   iXBRL 8-K 55968
2 EX-99.1 ex991-carsima_sharmapres.htm EX-99.1 9431
6 ex991-carsima_sharmapres001.jpg GRAPHIC 271283
7 ex991-carsima_sharmapres002.jpg GRAPHIC 283986
8 ex991-carsima_sharmapres003.jpg GRAPHIC 129180
  Complete submission text file 0001485003-23-000014.txt   1160266

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20230131.xsd EX-101.SCH 1902
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20230131_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20230131_pre.xml EX-101.PRE 13046
10 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20230131_htm.xml XML 11838
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 23572514
SIC: 2834 Pharmaceutical Preparations